DeLuca Richard R. — SEC insider filings
SEC reporting owner CIK 1421339. 24 insider filings on record with FilingPulse; latest filed 2026-11-16.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2021-03-02 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 9 filings — 662,406 shares, $71,911,960 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 164,557 shares @ $100.26 ($16,499,094) in Merck & Co., Inc., filed 2022-11-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | EVP&Pres, Merck Animal Heallth | 24 | — | 16 legs · 662,406 sh · $71,911,960 | 38 |
Insider filings — DeLuca Richard R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-16 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 58,185 @ $77.62 · Sale (S): 58,185 @ $148.01 · Option exercise (M): 58,185 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 20,784 @ $130.43 · Sale (S): 7,410 @ $131.33 · Sale (S): 5,427 @ $132.35 · Sale (S): 11,099 @ $131.61 · Sale (S): 600 @ $132.04 | EDGAR |
| 2026-08-10 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 805 @ $131.02 · Sale (S): 4,945 @ $130.23 · Sale (S): 300 @ $131.02 | EDGAR |
| 2026-05-07 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 11,931 (derivative) @ $0 · Grant/award (A): 34,924 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 2,518 @ $110.03 · Tax withholding (F): 1,241 @ $110.03 · Option exercise (M): 2,518 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 37,685 @ $120.92 | EDGAR |
| 2026-01-28 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 12,264 @ $107.40 | EDGAR |
| 2025-05-01 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 7,555 (derivative) @ $0 · Grant/award (A): 34,390 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 25,438 @ $97.94 | EDGAR |
| 2024-05-06 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 27,126 @ $127.51 · Tax withholding (F): 13,360 @ $127.51 · Option exercise (M): 27,126 (derivative) @ $0 | EDGAR |
| 2024-05-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 23,216 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-01-24 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 23,296 @ $119.43 | EDGAR |
| 2023-11-09 | 4 | Merck & Co., Inc. (MRK) | Sale (S): 43,823 @ $105.03 | EDGAR |
| 2023-05-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 44,260 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 66,163 @ $62.07 · Sale (S): 66,163 @ $115.00 · Option exercise (M): 75,436 @ $56.04 · Sale (S): 75,436 @ $116.03 · Option exercise (M): 66,163 (derivative) @ $0 · Option exercise (M): 75,436 (derivative) @ $0 | EDGAR |
| 2023-01-25 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 15,628 @ $109.88 | EDGAR |
| 2022-11-01 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 59,564 @ $0 · Option exercise (M): 104,993 @ $0 · Sale (S): 164,557 @ $100.26 · Option exercise (M): 59,564 (derivative) @ $0 · Option exercise (M): 104,993 (derivative) @ $0 | EDGAR |
| 2022-05-05 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 58,252 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 15,966 @ $73.51 | EDGAR |
| 2021-11-05 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 29,782 @ $0 · Sale (S): 29,782 @ $90.40 · Option exercise (M): 29,782 (derivative) @ $0 | EDGAR |
| 2021-11-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 26,319 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | Merck & Co., Inc. (MRK) | Option exercise (M): 73,026 @ $0 · Option exercise (M): 62,379 @ $0 · Sale (S): 135,405 @ $87.56 · Option exercise (M): 73,026 (derivative) @ $0 · Option exercise (M): 62,379 (derivative) @ $0 | EDGAR |
| 2021-05-06 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 82,653 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 25,510 @ $72.62 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1421339 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs